Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. - Wikidata - awgldk - TriplyDB

Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.

Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.

http://www.wikidata.org/entity/Q34616814

about

Radiotherapy combination opportunities leveraging immunity for the next oncology practice Cancer Stem Cell Hierarchy in Glioblastoma Multiforme Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway Targeting TGF-β signaling in cancer Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy MicroRNA and signal transduction pathways in tumor radiation response Targeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular Hypoxia Doxorubicin-mediated bone loss in breast cancer bone metastases is driven by an interplay between oxidative stress and induction of TGFβ Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia TGFbeta in Cancer Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function Doxorubicin in combination with a small TGFbeta inhibitor: a potential novel therapy for metastatic breast cancer in mouse models Modulation of NFkappaB activity and E-cadherin by the type III transforming growth factor beta receptor regulates cell growth and motility An open letter to the FDA and other regulatory agencies: Preclinical drug development must consider the impact on metastasis.Metastasis: a therapeutic target for cancer.Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells Meta-analysis of the rs4779584 polymorphism and colorectal cancer risk.Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials Targeting the transforming growth factor-beta signaling pathway in human cancer.Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting Two faces of TGF-beta1 in breast cancer.Suppression of uPAR retards radiation-induced invasion and migration mediated by integrin β1/FAK signaling in medulloblastoma.Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer.TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells.TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells Molecular mechanisms and treatment of radiation-induced lung fibrosis Bone marrow osteoblast damage by chemotherapeutic agents.Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B.Tgf-beta signaling pathway in lung adenocarcinoma invasion.The α₂β₁ integrin is a metastasis suppressor in mouse models and human cancer.High antimetastatic efficacy of MEN4901/T-0128, a novel camptothecin carboxymethyldextran conjugate Phosphorylation of ΔNp63α via a novel TGFβ/ALK5 signaling mechanism mediates the anti-clonogenic effects of TGFβ.The role of alveolar epithelium in radiation-induced lung injury A genome-wide association scan on estrogen receptor-negative breast cancer Transforming growth factor-β and the hallmarks of cancer.Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma.NRF2 deficiency reduces life span of mice administered thoracic irradiation.Differential knockdown of TGF-β ligands in a three-dimensional co-culture tumor- stromal interaction model of lung cancer.

P2860

Q26738443-ABC2C273-0321-4BAB-A7CB-800763534B96 Q26752312-2EAD68B4-7FA5-44CB-B214-311F36B653D3 Q26777016-3A7E1542-0FEF-4DB5-B211-94CB8C444D0B Q26797238-4C1E4CED-DC83-4698-BC76-BE617D7521DC Q27012443-87E7F4BD-99C5-4C89-8E20-0FC0AF9CF09F Q27021750-F77B4F08-6D61-497D-AF60-AD648EE4D29F Q27027546-F1073773-F9C7-4E89-97E6-079FBD8C6F63 Q27300346-12D19821-DAF7-4B7B-A3B5-1B301837FB0F Q27303597-A4CFDBC5-DEC2-410A-AFB4-0AD5904C8072 Q28236628-E5B18879-8B87-4371-AC43-76AC9759C690 Q28288866-696D3168-6864-45A0-9C2E-C8819F38E970 Q28392070-374B7218-DC1A-4253-AA63-0534BEA2C70C Q28473783-A23AF5F4-545D-4DEE-9CAF-CACE7E6E1F9A Q28594979-2EF1FA7A-8E91-44BF-868E-C2D8AA451C41 Q30410564-AF7B6853-67CF-4A0D-A422-DF0D012925D7 Q30439221-28C1FD76-CBD0-43AA-A77E-67ED6D64E6B8 Q30529813-EFAC521A-0E17-40ED-9837-F69E2602E47E Q31152198-2A61854D-150F-4AE5-9306-55604F71C24B Q33398018-E12E5481-6236-4FB1-968F-5470F70448D7 Q33517772-4205A0AE-9EE7-4C03-9631-6910B6578F57 Q33605773-6664C61C-8924-4B9F-80D8-C15E84F987E8 Q33661529-03ECAAE5-EC80-4569-8621-D8D24BE2CD3F Q33707627-265CCE30-52AC-4AE1-B4DD-9847FF57B9AD Q33729015-9B6E0EA1-368E-4093-AB63-60621D7AE25E Q33936542-506A91AA-1464-4C78-B444-8DE0276CE477 Q34048144-5480F2AA-DD0B-4EA2-9341-764CFC07EAA2 Q34076526-A670C682-AD3D-4062-ACFF-4143949ED4D8 Q34142102-F0629027-2037-4F50-9164-6DB4846E2906 Q34170223-93847E84-3400-4BA5-B330-72483235531F Q34292287-63D04C06-2505-41FE-9E7E-62DB6A6F6BAB Q34356297-167C89AF-88F6-497D-9E7B-14D4D7F551D4 Q34428911-97804C8B-D251-44D9-A2D6-E041A74C0AAD Q34432610-6838204E-28E7-43A2-A2D0-1DF0AA581BDE Q34482997-BB0EE54C-8988-4E10-9D2E-BF6B4FA6EF23 Q34551617-12621C71-5B2B-41DF-8E9C-8EC627ABBDC7 Q34613513-285D9A7F-E444-49AE-B1FD-90378D33A053 Q34789300-1CBCBCF2-FE2A-4AE2-99A9-735CD4CF5A96 Q35117549-DECDF973-C01A-46B3-9EB9-859D3FF923D9 Q35165109-6FBAA37C-B737-4083-A0D1-75C937682B67 Q35222167-F1433C09-E6EC-48ED-B636-173D5E049876

P2860

Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.

http://www.wikidata.org/entity/Q34616814

description

2007 nî lūn-bûn

@nan

2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Inhibition of TGF-beta with ne ...... metastatic cancer progression.

@ast

Inhibition of TGF-beta with ne ...... metastatic cancer progression.

@en

Inhibition of TGF-beta with ne ...... metastatic cancer progression.

@nl

type

label

Inhibition of TGF-beta with ne ...... metastatic cancer progression.

@ast

Inhibition of TGF-beta with ne ...... metastatic cancer progression.

@en

Inhibition of TGF-beta with ne ...... metastatic cancer progression.

@nl

prefLabel

Inhibition of TGF-beta with ne ...... metastatic cancer progression.

@ast

Inhibition of TGF-beta with ne ...... metastatic cancer progression.

@en

Inhibition of TGF-beta with ne ...... metastatic cancer progression.

@nl

P1433

Q34616814-6CCACB06-F81A-4BD2-B015-16433555CF66

P1476

Q34616814-968C7BB2-0E57-4571-8AEB-32951186BEF5

P2093

Q34616814-0399A828-F1A9-4D5D-88B8-000A13B10BAF

Q34616814-2F5AC51F-DC62-4DFC-AFD7-DFE20FEB14DA

Q34616814-562CBCCF-DE8C-4B6A-A04D-B3B110D7BC0E

Q34616814-83CAB778-35D9-45C4-9C4C-668D13023B87

Q34616814-9CE4662A-74E3-430E-AB85-AF3815C7046E

Q34616814-BB00C9F0-3B9B-4EE2-B895-B15524D2738F

P2860

Q34616814-02CB4482-C1D6-4640-9E55-EC6326D670D3

Q34616814-0DD60658-27C5-499D-A917-A98C02E146A5

Q34616814-150F9272-5331-4C0F-B989-1212A11C82C1

Q34616814-19860D30-CC1F-4848-B02D-60233EE55DFC

Q34616814-1A27C4AB-D051-4445-AB02-8F1E9B2409BA

Q34616814-30BB5BF6-AB20-44A4-9C28-3FC217DB1147

Q34616814-3D0CCCF3-2520-4565-9A59-05484605001E

Q34616814-43AD4210-369A-49DC-AB82-BD2A2C43B25D

Q34616814-476955C3-B3DB-4888-86C0-A5E2DDB92B23

Q34616814-6302FB2C-1A93-4E48-802F-C866C145DDA1

P304

Q34616814-7545BD2A-0104-4410-9F36-D0B6A1205A8F

P31

Q34616814-5F7146E2-44FE-4823-9BF1-5CA4DC8C729E

P356

Q34616814-6B92A608-DECA-4B70-97C6-C5E3054BD410

P407

Q34616814-5C88EE1B-B8C3-4B4E-A008-3C4A2731CD39

P433

Q34616814-5BD2A077-9AE6-480C-B9DB-0A5A819FBE59

P478

Q34616814-D84FBDA2-BAAC-4730-B65B-522067721CEA

P50

Q34616814-C55B9076-DB6D-46C5-A614-FCC5C62B27A8

Q34616814-DAE52FEE-C30C-4A03-B0E6-89C9B9389D04

P577

Q34616814-0917CB1D-0369-4371-9268-420EF4263E8D

P698

Q34616814-42A86FB0-7DFA-49D0-99C2-189F9A8B943F

P921

Q34616814-225EB230-E2CE-49DB-9DC4-D1E18A8FA673

P932

Q34616814-D7FC8365-F4BF-481E-ABB6-DC89F0BFE0C5

P356

P1433

Journal of Clinical Investigation

P1476

Inhibition of TGF-beta with ne ...... metastatic cancer progression

@en

P2093

Anna Chytil

http://www.w3.org/2001/XMLSchema#string

Cammie Rinehart

http://www.w3.org/2001/XMLSchema#string

Carlos L Arteaga

http://www.w3.org/2001/XMLSchema#string

Marta Guix

http://www.w3.org/2001/XMLSchema#string

Swati Biswas

http://www.w3.org/2001/XMLSchema#string

Teresa C Dugger

http://www.w3.org/2001/XMLSchema#string

P2860

Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function

Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

Smad transcription factors

Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors

Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis

Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer

A critical step in metastasis: in vivo analysis of intravasation at the primary tumor.

TGF-beta signaling: positive and negative effects on tumorigenesis.

The effect of surgical wounding on tumour development.

P304

1305-1313

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI30740

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

Harold L. Moses

Michael L Freeman

P577

2007-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17415413

http://www.w3.org/2001/XMLSchema#string

P921

P932

1838926

http://www.w3.org/2001/XMLSchema#string